US panel to review paediatric use of three antipsychotics
06 May 2009
Sue Sutter
Sue.sutter@informa.com
The US
FDA's psychopharmacologic drugs advisory committee will meet on June 9th-10th to weigh whether new paediatric indications for three atypical antipsychotics should be granted.
As previously disclosed by
AstraZeneca, the panel will review applications for expanded use of Seroquel (quetiapine...
Please Login to read the full article.